Nanomedicine, Volume IIA: Biocompatibility

© 2003 Robert A. Freitas Jr. All Rights Reserved.

Robert A. Freitas Jr., Nanomedicine, Volume IIA: Biocompatibility, Landes Bioscience, Georgetown, TX, 2003


References 5900-5999

5900. R.B. Crandall, J.P. Thompson, D.H. Connor, P.B. McGreevy, C.A. Crandall, “Pathology of experimental infection with Brugia malayi in ferrets: comparison with occult filariasis in man,” Acta Trop. 41(December 1984):373-381.

5901. R.K. Shenoy, K. Sandhya, T.K. Suma, V. Kumaraswami, “A preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities,” Southeast Asian J. Trop. Med. Public Health 26(June 1995):301-305.

5902. M.J. Murphy, B. Kogan, J.A. Carlson, “Granulomatous lymphangitis of the scrotum and penis. Report of a case and review of the literature of genital swelling with sarcoidal granulomatous inflammation,” J. Cutan. Pathol. 28(September 2001):419-424.

5903. M.H. Dresden, A. Ewert, “Collagen metabolism in experimental filariasis,” J. Parasitol. 70(April 1984):208-212.

5904. W.C. Barbee, A. Ewert, D. Folse, “The combined effect of a cutaneo-lymphatic fungus, Sporothrix schenckii and a lymphatic-dwelling nematode, Brugia Malayi,” Trop. Geogr. Med. 29(March 1977):65-73.

5905. Y. Tang, G. Ghirlanda, N. Vaidehi, J. Kua, D.T. Mainz, W.A. Goddard III, W.F. DeGrado, D.A. Tirrell, “Stabilization of coiled-coil peptide domains by introduction of trifluoroleucine,” Biochemistry 40(6 March 2001):2790-2796.

5906. B. Bilgicer, A. Fichera, K. Kumar, “A coiled coil with a fluorous core,” J. Am. Chem. Soc. 123(16 May 2001):4393-4399.

5907. J.T. Anderson, P.L. Toogood, E.N. Marsh, “A short and efficient synthesis of L-5,5,5,5’,5’,5’-hexafluoroleucine from N-Cbz-L-serine,” Org. Lett. 4(28 November 2002):4281-4283.

5908. A. Niemz, D.A. Tirrell, “Self-association and membrane-binding behavior of melittins containing trifluoroleucine,” J. Am. Chem. Soc. 123(1 August 2001):7407-7413.

5909. C.D. Balaban, “Vestibular nucleus projections to the parabrachial nucleus in rabbits: implications for vestibular influences on the autonomic nervous system,” Exp. Brain Res. 108(March 1996):367-381; P.O. Gerrits, G. Holstege, “Pontine and medullary projections to the nucleus retroambiguus: a wheat germ agglutinin-horseradish peroxidase and autoradiographic tracing study in the cat,” J. Comp. Neurol. 373(16 September 1996):173-185; H. Ito, M. Seki, “Ascending projections from the area postrema and the nucleus of the solitary tract of Suncus murinus: anterograde tracing study using Phaseolus vulgaris leucoagglutinin,” Okajimas Folia Anat. Jpn. 75(May 1998):9-31.

5910. W.R. Shapiro, F. Plum, “Paroxysmal hypothermia and mutism accompanying agenesis of the corpus callosum,” Neurology (Minneap.) 17(1967):317; W.R. Shapiro, G.H. Williams, F. Plum, “Spontaneous recurrent hypothermia accompanying agenesis of the corpus callosum,” Brain 92(1969):423-436.

5911. C.M. Segeren, K.H. Polderman, P. Lips, “Agenesis of the corpus callosum associated with paroxysmal hypothermia: Shapiro’s syndrome,” Neth. J. Med. 50(January 1997):29-35.

5912. C.J. Klein, M.H. Silber, J.R. Halliwill, S.A. Schreiner, G.A. Suarez, P.A. Low, “Basal forebrain malformation with hyperhidrosis and hypothermia: variant of Shapiro’s syndrome,” Neurology 56(23 January 2001):254-256; A.T. Wright, Neurology 58(12 February 2002):508-509 (comment).

5913. R.H. Fox, T.W. Davies, F.P. Marsh, H. Urich, “Hypothermia in a young man with an anterior hypothalamic lesion,” Lancet 2(25 July 1970):185-188.

5914. G.D. Summers, A.C. Young, R.A. Little, H.B. Stoner, W.S. Forbes, R.A. Jones, “Spontaneous periodic hypothermia with lipoma of the corpus callosum,” J. Neurol. Neurosurg. Psychiatry 44(December 1981):1094-1099.

5915. K. Hirayama, Y. Hoshino, H. Kumashiro, T. Yamamoto, “Reverse Shapiro’s syndrome. A case of agenesis of corpus callosum associated with periodic hyperthermia,” Arch. Neurol. 51(May 1994):494-496; J.S. Jeret, “Reverse Shapiro’s syndrome revisited,” Arch. Neurol. 52(June 1995):547.

5916. L.C. Walker, H. LeVine 3rd, “Proteopathy: the next therapeutic frontier?” Curr. Opin. Investig. Drugs 3(May 2002):782-787; L.C. Walker, F. Bian, M.J. Callahan, W.J. Lipinski, R.A. Durham, H. LeVine, “Modeling Alzheimer’s disease and other proteopathies in vivo: Is seeding the key?” Amino Acids 23(2002):87-93; L.C. Walker, H. LeVine, “The cerebral proteopathies: neurodegenerative disorders of protein conformation and assembly,” Mol. Neurobiol. 21(February-April 2000):83-95.

5917. Yan Zhang, Richard McLaughlin, Cynthia Goodyer, Andrea LeBlanc, “Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons,” J. Cell Biol. 156(4 February 2002):519-529;

5918. J. Cohen, “Comparison of the sensitivity of three methods for the rapid identification of Cryptococcus neoformans,” J. Clin. Pathol. 37(March 1984):332-334; A.A. Gal, S. Evans, P.R. Meyer, “The clinical laboratory evaluation of cryptococcal infections in the acquired immunodeficiency syndrome,” Diagn. Microbiol. Infect. Dis. 7(August 1987):249-254; P. Sanchetee, “Cryptococcal meningitis in immunocompetent patients,” J. Assoc. Physicians India 46(July 1998):617-619.

5919. J.C. Antoine, M. Tommasi, A. Chalumeau, A. Jouvet-Telinge, C. Bourrat, “Hallervorden-Spatz disease with Lewy bodies,” Rev. Neurol. (Paris) 141(1985):806-809. In French.

5920. K. Kosaka, “Diffuse Lewy body disease,” Neuropathology 20(September 2000):S73-S78.

5921. A.H. Koeppen, A.C. Dickson, “Iron in the Hallervorden-Spatz syndrome,” Pediatr. Neurol. 25(August 2001):148-155.

5922. H. Kuchiwaki, T. Kobayashi, T. Takahashi, T. Kitano, K. Yoshiko, “Iron in cicatrix and abnormal CT findings in a patient with posttraumatic epilepsy,” Neurochirurgia (Stuttg.) 32(July 1989):116-119.

5923. L.J. Willmore, G.W. Sypert, J.V. Munson, R.W. Hurd, “Chronic focal epileptiform discharges induced by injection of iron into rat and cat cortex,” Science 200(30 June 1978):1501-1503; L.J. Willmore, G.W. Sypert, J.B. Munson, “Recurrent seizures induced by cortical iron injection: a model of posttraumatic epilepsy,” Ann. Neurol. 4(October 1978):329-336; L.J. Willmore, J.J. Rubin, “Antiperoxidant pretreatment and iron-induced epileptiform discharges in the rat: EEG and histopathologic studies,” Neurology 31(January 1981):63-69; K.F. Swaiman, “Hallervorden-Spatz syndrome and brain iron metabolism,” Arch. Neurol. 48(December 1991):1285-1293.

5924. Statistical Abstract of the United States: 1996, 116th Edition, U.S. Bureau of the Census, Washington DC, 1996.

5925. J.L. Selam, “External and implantable insulin pumps: current place in the treatment of diabetes,” Exp. Clin. Endocrinol. Diabetes 109(2001):S333-S340.

5926. P. Martelletti, E. Adriani, S. Bonini, D. Celestino, L. Lenti, C. Armaleo, A. Di Pastena, R. Misasi, M. Giacovazzo, “Basophil histamine release and leukotriene (LTB4-LTC4) production in cluster headache,” Headache 29(January 1989):46-48.

5927. B.F. Gibbs, H. Haas, F.H. Falcone, C. Albrecht, I.B. Vollrath, T. Noll, H.H. Wolff, U. Amon, “Purified human peripheral blood basophils release interleukin-13 and preformed interleukin-4 following immunological activation,” Eur. J. Immunol. 26(October 1996):2493-2498.

5928. J.A. Schifferli, G. Steiger, J.P. Paccaud, “Complement mediated inhibition of immune precipitation and solubilization generate different concentrations of complement anaphylatoxins (C4a, C3a, C5a),” Clin. Exp. Immunol. 64(May 1986):407-414.

5929. R. Dall’Amico, C. Messina, “Extracorporeal photochemotherapy for the treatment of graft-versus-host disease,” Ther. Apher. 6(August 2002):296-304; F.M. Foss, G. Gorgun, K.B. Miller, “Extracorporeal photopheresis in chronic graft-versus-host disease,” Bone Marrow Transplant 29(May 2002):719-725; A. Oliven, Y. Shechter, “Extracorporeal photopheresis: a review,” Blood Rev. 15(June 2001):103-108; J.A. Zic, J.L. Miller, G.P. Stricklin, L.E. King Jr., “The North American experience with photopheresis,” Ther. Apher. 3(February 1999):50-62; G. Crovetti, A. Carabelli, E. Berti, M. Guizzardi, S. Fossati, C. De Filippo, E. Bertani, “Photopheresis in cutaneous T-cell lymphoma: five-year experience,” Int. J. Artif. Organs 23(January 2000):55-62.

5930. M.A. Lane, D.J. Baer, W.V. Rumpler, R. Weindruch, D.K. Ingram, E.M. Tilmont, R.G. Cutler, G.S. Roth, “Calorie restriction lowers body temperature in rhesus monkeys, consistent with a postulated anti-aging mechanism in rodents,” Proc. Natl. Acad. Sci. (USA) 93(30 April 1996):4159-4164;; J. Wanagat, D.B. Allison, R. Weindruch, “Caloric intake and aging: mechanisms in rodents and a study in nonhuman primates,” Toxicol. Sci. 52(December 1999):35-40.

5931. P.H. Duffy, R. Feuers, K.D. Nakamura, J. Leakey, R.W. Hart, “Effect of chronic caloric restriction on the synchronization of various physiological measures in old female Fischer 344 rats,” Chronobiol. Int. 7(1990):113-124.

5932. M.A. Lane, D.K. Ingram, G.S. Roth, “Calorie restriction in nonhuman primates: effects on diabetes and cardiovascular disease risk,” Toxicol. Sci. 52(December 1999):41-48.

5933. C.P. Yu, G.B. Xu, “Predictive models for deposition of inhaled diesel exhaust particles in humans and laboratory species,” Res. Rep. Health Eff. Inst. 10(1987):3-22.

5934. M. Leist, B. Single, A.F. Castoldi, S. Kuhnle, P. Nicotera, “Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis,” J. Exp. Med. 185(21 April 1997):1481-1486;

5935. O.Y. Grinberg, P.E. James, H.M. Swartz, “Are there significant gradients of pO2 in cells?” Adv. Exp. Med. Biol. 454(1998):415-423.

5936. D.P. Jones, “Intracellular diffusion gradients of O2 and ATP,” Am. J. Physiol. 250(May 1986):C663-C675.

5937. S.B. Horowitz, D.S. Miller, “Solvent properties of ground substance studied by cryomicrodissection and intracellular reference-phase techniques,” J. Cell Biol. 99(July 1984):172s-179s.

5938. L. Tluczek, Y.T. Lau, S.B. Horowitz, “Water, potassium, and sodium during amphibian oocyte development,” Dev. Biol. 104(July 1984):97-105.

5939. M. Wahl, R.G. Sleight, E. Gruenstein, “Association of cytoplasmic free Ca2+ gradients with subcellular organelles,” J. Cell Physiol. 150(March 1992):593-609.

5940. S.B. Horowitz, T.W. Pearson, “Intracellular monosaccharide and amino acid concentrations and activities and the mechanisms of insulin action,” Mol. Cell Biol. 1(September 1981):769-784.

5941. C. Deutsch, M. Erecinska, R. Werrlein, I.A. Silver, “Cellular energy metabolism, trans-plasma and trans-mitochondrial membrane potentials, and pH gradients in mouse neuroblastoma,” Proc. Natl. Acad. Sci. (USA) 76(May 1979):2175-2179.

5942. F.M. Gribble, G. Loussouarn, S.J. Tucker, C. Zhao, C.G. Nichols, F.M. Ashcroft, “A novel method for measurement of submembrane ATP concentration,” J. Biol. Chem. 275(29 September 2000):30046-30049;

5943. H. Khoury, D. Adkins, R. Brown, H. Pence, R. Vij, L.T. Goodnough, P. Westervelt, K. Trinkaus, H.S. Lin, Y. DiPersio, “Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen,” Biol. Blood Marrow Transplant. 7(2001):352-358; W.S. Wang, C.H. Tzeng, R.K. Hsieh, T.J. Chiou, J.H. Liu, C.C. Yen, P.M. Chen, “Successful pregnancy following very high-dose total body irradiation (1575 cGy) and bone marrow transplantation in a woman with acute myeloid leukemia,” Bone Marrow Transplant. 21(February 1998):415-417; G.W. Santos, “Busulfan and cyclophosphamide versus cyclophosphamide and total body irradiation for marrow transplantation in chronic myelogenous leukemia – a review,” Leuk. Lymphoma 11(1993):201-204.

5944. J.L. Schultze, J.W. Donovan, J.G. Gribben, “Minimal residual disease detection after myeloablative chemotherapy in chronic lymphatic leukemia,” J. Mol. Med. 77(February 1999):259-265.

5945. M.C. Genovese, Z. Uhrin, D.A. Bloch, J. Oehlert, R.K. Sibley, B. Myers, S. Strober, “Long-term followup of patients treated with total lymphoid irradiation for lupus nephritis,” Arthritis Rheum. 46(April 2002):1014-1018.

5946. S.M. Rigby, T. Rouse, E.H. Field, “Total lymphoid irradiation nonmyeloablative preconditioning enriches for IL-4 producing CD4+-TNK cells and skews differentiation of immunocompetent donor CD4+ cells,” Blood 101(1 March 2003):2024-2032.

5947. K.J. Radford, Darren E. Higgins, S. Pasquini, E.J. Cheadle, L. Carta, A.M. Jackson, N.R. Lemoine, G. Vassaux, “A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy,” Gene Ther. 9(November 2002):1455-1463. See also: “Food pathogen vector shows promise against cancer; E. coli, Listeria take on melanoma,” 6 November 2002;

5948. Andreas G. Niethammer, Rong Xiang, Jurgen C. Becker, Harald Wodrich, Ursula Pertl, Gabriele Karsten, Brian P. Eliceiri, Ralph A. Reisfeld, “A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth,” Nat. Med. 8(December 2002):1369-1375. See also: “Scripps Research Institute group designs DNA vaccine that inhibits growth of cancerous tumors,” 5 November 2002;

5949. S.A. Berceli, M.G. Davies, R.D. Kenagy, A.W. Clowes, “Flow-induced neointimal regression in baboon polytetrafluoroethylene grafts is associated with decreased cell proliferation and increased apoptosis,” J. Vasc. Surg. 36(December 2002):1248-1255.

5950. F. Akimaro Kudo, T. Nishibe, K. Miyazaki, S. Watanabe, J. Flores, K. Yasuda, “Induction of apoptosis after stent implantation in canine portal vein,” Ann. Vasc. Surg. 16(July 2002):456-461.

5951. E. Sho, M. Sho, T.M. Singh, C. Xu, C.K. Zarins, H. Masuda, “Blood flow decrease induces apoptosis of endothelial cells in previously dilated arteries resulting from chronic high blood flow,” Arterioscler. Thromb. Vasc. Biol. 21(July 2001):1139-1145; See also: A. Cho, L. Mitchell, D. Koopmans, B.L. Langille, “Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits,” Circ. Res. 81(September 1997):328-337;

5952. M. Kalra, V.M. Miller, “Early remodeling of saphenous vein grafts: proliferation, migration and apoptosis of adventitial and medial cells occur simultaneously with changes in graft diameter and blood flow,” J. Vasc. Res. 37(November-December 2000):576-584.

5953. B. Meyrick, L. Reid, “Endothelial and subintimal changes in rat hilar pulmonary artery during recovery from hypoxia. A quantitative ultrastructural study,” Lab. Invest. 42(June 1980):603-615.

5954. S. Roberge, Y. Boucher, P.E. Roy, “Transient ultrastructural variations of pulmonary lymphatic capillaries during the respiratory cycle of the rat lung,” Anat. Rec. 213(December 1985):551-559.

5955. A. Koch, T.M. Bingold, J. Oberlander, F.U. Sack, H.F. Otto, S. Hagl, P.A. Schnabel, “Capillary endothelia and cardiomyocytes differ in vulnerability to ischemia/reperfusion during clinical heart transplantation,” Eur. J. Cardiothorac. Surg. 20(November 2001):996-1001.

5956. D.S. Robertson, “The percussion reactions involved in brain function,” Med. Hypotheses 59(November 2002):682-695.

5957. T. Orfeo, J.M. Doherty, G. Adey, P.L. Penar, M.A. Shatos, “Sublethal percussion trauma in vitro causes a persisting derangement in the nonthrombogenic properties of brain endothelial cells,” J. Trauma 37(September 1994):347-357.

5958. C.G. Gourin, S.R. Shackford, “Production of tumor necrosis factor-alpha and interleukin-1beta by human cerebral microvascular endothelium after percussive trauma,” J. Trauma 42(June 1997):1101-1107.

5959. C.G. Gourin, S.R. Shackford, “Influence of percussion trauma on expression of intercellular adhesion molecule-1 (ICAM-1) by human cerebral microvascular endothelium,” J. Trauma 41(July 1996):129-135.

5960. C.F. Dewey Jr., S.R. Bussolari, M.A. Gimbrone Jr., P.F. Davies, “The dynamic response of vascular endothelial cells to fluid shear stress,” J. Biomech. Eng. 103(August 1981):177-185.

5961. Michael A. Gimbrone, Jr., Vascular Endothelium in Hemostasis and Thrombosis, Churchill Livingstone, New York, 1987; Raymund MacHovich, ed., Blood Vessel Wall and Thrombosis, CRC Press, Boca Raton, FL, 1988.

5962. C.L. Tock, J.P. Bosley, S.M. Parnis, F.J. Clubb Jr., M.P. Macris, O.H. Frazier, T. Scott-Burden, “A genetically engineered, nonthrombogenic cellular lining for LVADs: in vitro preconditioning before in vivo implantation,” ASAIO J. 45(May-June 1999):172-177; T. Scott-Burden, C.L. Tock, J.P. Bosely, F.J. Clubb Jr., S.M. Parnis, J.J. Schwarz, D.A. Engler, O.H. Frazier, S.W. Casscells 3rd, Circulation 98(10 November 1998):II339-II345.

5963. R.J. Gryglewski, R.M. Botting, J.R. Vane, “Mediators produced by the endothelial cell,” Hypertension 12(December 1988):530-548.

5964. P.I. Lelkes, M.M. Samet, “Endothelialization of the luminal sac in artificial cardiac prostheses: a challenge for both biologists and engineers,” J. Biomech. Eng. 113(May 1991):132-142.

5965. P. Zilla, “Endothelialization of vascular grafts,” Curr. Opin. Cardiol. 6(December 1991):877-886.

5966. M.J. Wissink, R. Beernink, A.A. Poot, G.H. Engbers, T. Beugeling, W.G. van Aken, J. Feijen, “Improved endothelialization of vascular grafts by local release of growth factor from heparinized collagen matrices,” J. Control. Release 64(14 February 2000):103-114.

5967. H.J. Salacinski, N.R. Tai, G. Punshon, A. Giudiceandrea, G. Hamilton, A.M. Seifalian, “Optimal endothelialisation of a new compliant poly(carbonate-urea)urethane vascular graft with effect of physiological shear stress,” Eur. J. Vasc. Endovasc. Surg. 20(October 2000):342-352.

5968. P. Fernandez, R. Bareille, V. Conrad, D. Midy, L. Bordenave, “Evaluation of an in vitro endothelialized vascular graft under pulsatile shear stress with a novel radiolabeling procedure,” Biomaterials 22(April 2001):649-658.

5969. A. Rademacher, M. Paulitschke, R. Meyer, R. Hetzer, “Endothelialization of PTFE vascular grafts under flow induces significant cell changes,” Int. J. Artif. Organs 24(April 2001):235-242.

5970. T.R. Santhosh Kumar, L.K. Krishnan, “A stable matrix for generation of tissue-engineered nonthrombogenic vascular grafts,” Tissue Eng. 8(October 2002):763-770.

5971. C. Wang, Q. Zhang, S. Uchida, M. Kodama, “A new vascular prosthesis coated with polyamino-acid urethane copolymer (PAU) to enhance endothelialization,” J. Biomed. Mater. Res. 62(5 December 2002):315-322.

5972. P.J. Paddison, A.A. Caudy, G.J. Hannon, “Stable suppression of gene expression by RNAi in mammalian cells,” Proc. Natl. Acad. Sci. (USA) 99(5 February 2002):1443-1448;

5973. M.F. Mette, W. Aufsatz, J. van der Winden, M.A. Matzke, A.J. Matzke, “Transcriptional silencing and promoter methylation triggered by double-stranded RNA,” EMBO J. 19(2 October 2000):5194-5201;; W. Tang, X.Y. Luo, V. Sanmuels, “Gene silencing: double-stranded RNA mediated mRNA degradation and gene inactivation,” Cell Res. 11(September 2001):181-186; A. Fjose, S. Ellingsen, A. Wargelius, H.C. Seo, “RNA interference: mechanisms and applications,” Biotechnol. Annu. Rev. 7(2001):31-57; E. Ullu, A. Djikeng, H. Shi, C. Tschudi, “RNA interference: advances and questions,” Philos. Trans. R. Soc. Lond. B Biol. Sci. 357(29 January 2002):65-70; H. Cerutti, “RNA interference: traveling in the cell and gaining functions?” Trends Genet. 19(January 2003):39-46.

5974. Y. Zeng, B.R. Cullen, “RNA interference in human cells is restricted to the cytoplasm,” RNA 8(July 2002):855-860.

5975. C. Lipardi, Q. Wei, B.M. Paterson, “RNAi as random degradative PCR: siRNA primers convert mRNA into dsRNAs that are degraded to generate new siRNAs,” Cell 107(2 November 2001):297-307.

5976. P.D. Zamore, “Ancient pathways programmed by small RNAs,” Science 296(17 May 2002):1265-1269.

5977. S.L. Lin, S.Y. Ying, “D-RNAi (messenger RNA-antisense DNA interference) as a novel defense system against cancer and viral infections,” Curr. Cancer Drug Targets 1(November 2001):241-247.

5978. S.L. Lin, C.M. Chuong, S.Y. Ying, “A novel mRNA-cDNA interference phenomenon for silencing bcl-2 expression in human LNCaP cells,” Biochem. Biophys. Res. Commun. 281(2 March 2001):639-644.

5979. V. Norris, T. Onoda, H. Pollaert, G. Grehan, “The mechanical advantages of DNA,” Biosystems 49(January 1999):71-78.

5980. C. Hoischen, C. Fritsche, J. Gumpert, M. Westermann, K. Gura, B. Fahnert, “Novel bacterial membrane surface display system using cell wall-less L-forms of Proteus mirabilis and Escherichia coli,” Appl. Environ. Microbiol. 68(February 2002):525-531;; C.M. Innes, E.J. Allan, “Induction, growth and antibiotic production of Streptomyces viridifaciens L-form bacteria,” J. Appl. Microbiol. 90(March 2001):301-308; J. Gumpert, C. Hoischen, “Use of cell wall-less bacteria (L-forms) for efficient expression and secretion of heterologous gene products,” Curr. Opin. Biotechnol. 9(October 1998):506-509.

5981. Martin Bier, Wei Chen, T.R. Gowrishankar, R. Dean Astumian, Raphael C. Lee, “Resealing dynamics of a cell membrane after electroporation,” Phys. Rev. E 66(2003):062905.

5982. NIOSH Hazard Review, “Chapter 4. Experimental Studies,” in Health Effects of Occupational Exposure to Respirable Crystalline Silica, Department of Health and Human Services, Centers for Disease Control and Prevention, National Institute for Occupational Safety and Health, DHHS (NIOSH) Publication No. 2002-129, April 2002;

5983. V. Castranova, V. Vallyathan, “Silicosis and coal workers’ pneumoconiosis,” Environ. Health Perspect. 108(August 2000):675-684; N.L. Lapp, V. Castranova, “How silicosis and coal workers’ pneumoconiosis develop: A cellular assessment,” Occup. Med.: State of the Art Rev. 8(1993):35-56.

5984. E. Donetti, R. Baetta, C. Comparato, C. Altana, S. Sartore, R. Paoletti, P. Castano, G. Gabbiani, A. Corsini, “Polymorphonuclear leukocyte-myocyte interaction: an early event in collar-induced rabbit carotid intimal thickening,” Exp. Cell Res. 274(1 April 2002):197-206.

5985. Z. Kinkor, P. Mukensnabl, M. Michal, “Inflammatory myxohyaline tumor with massive emperipolesis,” Pathol. Res. Pract. 198(2002):639-642.

5986. S. Saxena, K.R. Beena, A. Bansal, A. Bhatnagar, “Emperipolesis in a common breast malignancy. A case report,” Acta Cytol. 46(September-October 2002):883-886.

5987. J. Dzieciol, D. Lemancewicz, J. Kloczko, W. Boguslowicz, A. Lebelt, “Megakaryocytes emperipolesis in bone marrow of the patients with non-Hodgkin’s lymphoma,” Folia Histochem. Cytobiol. 39(2001):142-143.

5988. C.L. Garon, M.A. Scott, K.A. Selting, L.A. Cohn, “Idiopathic thrombocytopenic purpura in a cat,” J. Am. Anim. Hosp. Assoc. 35(November-December 1999):464-470.

5989. D. Aslan, S. Yetgin, “Megakaryocyte emperipolesis in a child with chronic neutropenia: an unusual coexistence,” Turk. J. Pediatr. 43(July-September 2001):255-256.

5990. A. Schmitt, H. Jouault, J. Guichard, F. Wendling, A. Drouin, E.M. Cramer, “Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis,” Blood 96(15 August 2000):1342-1347;

5991. A. Schmitt, A. Drouin, J.M. Masse, J. Guichard, H. Shagraoui, E.M. Cramer, “Polymorphonuclear neutrophil and megakaryocyte mutual involvement in myelofibrosis pathogenesis,” Leuk. Lymphoma 43(April 2002):719-724.

5992. T.C. Falik-Zaccai, Y. Anikster, C.E. Rivera, M.K. Horne 3rd, L. Schliamser, C. Phornphutkul, D. Attias, T. Hyman, J.G. White, W.A. Gahl, “A new genetic isolate of gray platelet syndrome (GPS): clinical, cellular, and hematologic characteristics,” Mol. Genet. Metab. 74(November 2001):303-313.

5993. V.K. Douglas, M.S. Tallman, L.D. Cripe, L.C. Peterson, “Thrombopoietin administered during induction chemotherapy to patients with acute myeloid leukemia induces transient morphologic changes that may resemble chronic myeloproliferative disorders,” Am. J. Clin. Pathol. 117(June 2002):844-850.

5994. A.Y. Nerurkar, S. Krishnamurthy, “Emperipolesis as a key feature in imprint cytology of the thymus. A report of two cases,” Acta Cytol. 44(November-December 2000):1059-1061.

5995. W.B. Lee, S.K. Erm, K.Y. Kim, R.P. Becker, “Emperipolesis of erythroblasts within Kupffer cells during hepatic hemopoiesis in human fetus,” Anat. Rec. 256(1 October 1999):158-164.

5996. A. Salim, M. Williamson, F. Barker, J. Hughes, “Steroid responsive cutaneous Rosai-Dorfman disease associated with uveitis and hypothyroidism,” Clin. Exp. Dermatol. 27(June 2002):277-279.

5997. T. Brenn, E. Calonje, S.R. Granter, N. Leonard, W. Grayson, C.D. Fletcher, P.H. McKee, “Cutaneous Rosai-Dorfman disease is a distinct clinical entity,” Am. J. Dermatopathol. 24(October 2002):385-391.

5998. G. Kroumpouzos, M.F. Demierre, “Cutaneous rosai-dorfman disease: histopathological presentation as inflammatory pseudotumor. A literature review,” Acta Derm. Venereol. 82(2002):292-296.

5999. R. Kitai, J. Llena, A. Hirano, K. Ido, K. Sato, T. Kubota, “Meningeal Rosai-Dorfman disease: report of three cases and literature review,” Brain Tumor Pathol. 18(2001):49-54.


Last updated on 16 April 2004